Richard Imrich
Overview
Explore the profile of Richard Imrich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
955
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taylor S, Dobbin N, Imrich R, Arnoux J, Ranganath L
Disabil Rehabil
. 2025 Jan;
1-6.
PMID: 39772935
Purpose: To report active and passive hip range of motion (ROM) data for individuals with alkaptonuria (AKU), with consideration for age, sex, and non-AKU comparative data. Materials And Methods: Using...
2.
Boca R, Imrich R, Stofko J, Vranovicova B, Rajnak C
J Phys Chem A
. 2024 Sep;
128(38):8088-8095.
PMID: 39264349
Four branched-chain aliphatic α-amino acids─α-alanine, valine, leucine, and isoleucine (-)─were investigated by quantum-chemical calculations in water as a solvent by two methods. The B3LYP variant of DFT calculations was used...
3.
Rajnak C, Imrich R, Stofko J, Matonok A, Boca R
ACS Omega
. 2024 Sep;
9(34):36086-36098.
PMID: 39220496
Three neurotransmitters belonging to catecholamines (dopamine, noradrenaline, adrenaline) and related α-amino acids (DOPA and tyrosine) were studied by quantum-chemical and DFT calculations using B3LYP and DLPNO-CCSD(T) methods in water. In...
4.
Zatkova A, Olsson B, Ranganath L, Imrich R
Metabolites
. 2024 Jun;
14(6).
PMID: 38921482
In the original publication [...].
5.
Radikova Z, Mosna L, Eckerstorfer C, Bajer B, Havranova A, Imrich R, et al.
Endocr Regul
. 2024 Jun;
58(1):115-128.
PMID: 38861537
Sedentary lifestyle increasingly observed in the population contributes to the incremental incidence of obesity, cardiovascular diseases, mental disorders, type 2 diabetes, hyper-tension, dyslipidemia, and others. Physical inactivity together with an...
6.
Boca R, Imrich R, Stofko J, Vranovicova B, Rajnak C
Amino Acids
. 2024 Feb;
56(1):5.
PMID: 38300332
Four linear amino acids of increased separation of the carboxyl and amino groups, namely glycine (aminoacetic acid), β-alanine (3-aminopropanoic acid), GABA (4-aminobutanoic acid) and DAVA (5-aminopentanoic acid), have been studied...
7.
Imrich R, Stofko J, Boca R, Rajnak C
J Mol Model
. 2023 Nov;
29(12):370.
PMID: 37953387
Context: Nitisinone is a medium-sized organic molecule that is used in treating hereditary tyrosinemia type 1 (HT-1). The structurally analogous mesotrione, however, is used as a pesticide/herbicide. What molecular properties...
8.
Boca R, Stofko J, Imrich R
ACS Omega
. 2023 Aug;
8(31):28577-28582.
PMID: 37576642
o calculations of HF+MP2 and DFT-B3LYP quality have been used in calculating the molecular geometries and properties of neutral and charged molecules of glycine in amino acid as well as...
9.
Hardonova M, Siarnik P, Sivakova M, Sucha B, Penesova A, Radikova Z, et al.
Int J Mol Sci
. 2023 Jul;
24(13).
PMID: 37446338
Introduction: Epidemiological studies have suggested an increased vascular risk in patients with multiple sclerosis (MS). There is increasing evidence of the beneficial effects of GLP-1 agonists (GLP-1a) in preventing vascular...
10.
Boca R, Stofko J, Imrich R
J Mol Model
. 2023 Jul;
29(8):245.
PMID: 37442864
Context: l-Tyrosine is a naturally occurring agent that acts as a precursor in biosynthesis of monoaminergic neurotransmitters in brain such as dopamine, adrenaline, noradrenaline, and hormones like thyroxine and triiodothyronine....